Please know that during this challenging time of COVID-19, we are taking all measures to ensure the safety, health, and wellness of our employees and customers, which is our top priority. We also remain fully committed to achieving our clients' goals, and with a robust continuity plan in place, we stand ready and able to assist you in any way we can. Thank you for your continued partnership.
Certara Supported 90+ Percent of US FDA Novel New Drug Approvals for the Fourth Consecutive Year
Read the press release
Achieving Regulatory Success
As Certara's Regulatory Science Division, Synchrogenix accelerates the regulatory submissions of medical innovations worldwide through customized regulatory solutions, including strategy, communications, operations and technology.
FDA Renews Licenses for Synchrogenix's GlobalSubmit Software to Review and Validate New Drug and Biologics Applications
Read the press release
Achieving Regulatory Success
As Certara's Regulatory Science Division, Synchrogenix accelerates the regulatory submissions of medical innovations worldwide through customized regulatory solutions, including strategy, communications, operations and technology.
Visit us at DIA's Medical Affairs and Scientific Communications Forum
March 23-25 | Anaheim, CA
Learn More
Achieving Regulatory Success
As Certara's Regulatory Science Division, Synchrogenix accelerates the regulatory submissions of medical innovations worldwide through customized regulatory solutions, including strategy, communications, operations and technology.
GlobalSubmit WebReview is a Simple, Secure eCTD Viewer with Anytime, Anywhere Access
Try it at No Cost for 30 Days!
Learn More
Achieving Regulatory Success
As Certara's Regulatory Science Division, Synchrogenix accelerates the regulatory submissions of medical innovations worldwide through customized regulatory solutions, including strategy, communications, operations and technology.
Increase your product's chance of expedited approval and greater patient access with global program development guidance from seasoned experts. More.
Communicate with confidence beside a strategic partner who has the knowledgeable professionals and depth of expertise your scientific investment deserves. More.
Streamline your electronic submissions and file on time, if not sooner with dedicated publishing teams who are scalable and provide visibility throughout the entire process. More.
Advance your drug approvals utilizing the industry’s leading-edge technologies for writing and content reuse, submissions management, and transparency and disclosure. More.